PharmaCyte Biotech, Inc. (PMCB)
0.3422
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.3411
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Price to Book Value : 0.1335 for Oct. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 0.1335 |
| October 19, 2026 | 0.1335 |
| October 16, 2026 | 0.1328 |
| October 15, 2026 | 0.1395 |
| October 14, 2026 | 0.136 |
| October 13, 2026 | 0.1389 |
| October 12, 2026 | 0.1425 |
| October 09, 2026 | 0.1578 |
| October 08, 2026 | 0.1551 |
| October 07, 2026 | 0.1583 |
| October 06, 2026 | 0.1648 |
| October 05, 2026 | 0.1522 |
| October 02, 2026 | 0.1561 |
| October 01, 2026 | 0.1576 |
| September 30, 2026 | 0.1602 |
| September 29, 2026 | 0.1635 |
| September 28, 2026 | 0.1639 |
| September 25, 2026 | 0.1721 |
| September 24, 2026 | 0.1781 |
| September 23, 2026 | 0.1672 |
| September 22, 2026 | 0.1789 |
| September 21, 2026 | 0.1759 |
| September 18, 2026 | 0.1794 |
| September 17, 2026 | 0.1655 |
| September 16, 2026 | 0.1624 |
| Date | Value |
|---|---|
| September 15, 2026 | 0.1492 |
| September 14, 2026 | 0.153 |
| September 11, 2026 | 0.1757 |
| September 10, 2026 | 0.1726 |
| September 09, 2026 | 0.1855 |
| September 08, 2026 | 0.1908 |
| September 04, 2026 | 0.1899 |
| September 03, 2026 | 0.1917 |
| September 02, 2026 | 0.1876 |
| September 01, 2026 | 0.1905 |
| August 31, 2026 | 0.1955 |
| August 28, 2026 | 0.201 |
| August 27, 2026 | 0.2108 |
| August 26, 2026 | 0.2109 |
| August 25, 2026 | 0.2106 |
| August 24, 2026 | 0.2049 |
| August 21, 2026 | 0.208 |
| August 20, 2026 | 0.2007 |
| August 19, 2026 | 0.2078 |
| August 18, 2026 | 0.2045 |
| August 17, 2026 | 0.2116 |
| August 14, 2026 | 0.215 |
| August 13, 2026 | 0.2146 |
| August 12, 2026 | 0.2136 |
| August 11, 2026 | 0.2146 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.30 |
| Anika Therapeutics, Inc. | 1.993 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.119 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0003 |
| Price | 0.3422 |
| Earnings Yield | -701.2% |
| Market Cap | 3.674M |
| PEGY Ratio | -0.0003 |